Forbes August 23, 2023
Puerto Rico To Leverage New FDA Guidelines And Promote New Leadership In Healthcare
Historically, minorities are underrepresented in medical trials, despite the fact that the findings can ultimately benefit these groups in particular. Crucial for gauging medical product safety and efficacy, medical trials should mirror the diversity of future users. However, according to Food and Drug Administration data, 75% of medical trial participants in 2020 were white; only 11% were Hispanic, 8% were Black, and 6% were Asian.
Remarkably, even in innovation-oriented fields like medical research, diversity is lacking. In April, the FDA took substantial steps to increase racial and ethnic diversity in clinical trials, recognizing that the US population itself has become increasingly diversified. FDA Commissioner Robert M. Califf,...
Today's Sponsors
Today's Sponsor